Molecular docking analysis of MCL-1 inhibitors for breast cancer management

Myeloid leukemia 1 (MCL-1), a BCL-2 protein family member, acts as an anti-apoptotic protein by interacting with pro-apoptotic BCL-2 proteins. Its overexpression is frequently observed in numerous cancer types including breast cancer, and is closely linked to the initiation and progression of tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulrahman, Alzahrani, Mohammad Azhar, Kamal, Asif Hussain, Akber, Ali Abdullah, Asiri, Marui, Ibrahim Shafei, Mohammed Hadi, Ghawi, Hanan Mamdouh, Alotaibi, Qamre, Alam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598365/
https://www.ncbi.nlm.nih.gov/pubmed/37885779
http://dx.doi.org/10.6026/97320630019707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598365/
https://www.ncbi.nlm.nih.gov/pubmed/37885779
http://dx.doi.org/10.6026/97320630019707

Ejemplares similares